Resveratrol Effects on Molecular Pathways and MicroRNAs in Gastrointestinal Cancers

Amirhossein Davoodvandi1, Pouya Mahdavi Sharif1,2, Parisa Maleki Dana3

  • 1Cancer Immunology Project, Universal Scientific Education and Research Network, Tehran, Iran.

Insights

Resveratrol, a natural compound, shows promise in managing gastrointestinal (GI) cancers by influencing microRNAs. Further research into these molecular pathways could lead to new treatments for GI neoplasms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Products Chemistry

Background:

  • Gastrointestinal (GI) cancers represent a significant global health burden with increasing incidence.
  • Current treatment options for GI cancers are limited, necessitating novel therapeutic strategies.
  • Natural products, like resveratrol, are emerging as potential agents in cancer management.

Approach:

  • This review explores the molecular mechanisms of resveratrol relevant to cancer.
  • It specifically evaluates resveratrol's impact on microRNAs (miRNAs) in GI cancer.
  • The focus is on understanding resveratrol's role in GI cancer prevention and treatment.

Key Points:

  • Resveratrol, found in red grapes and tea, is a phytochemical with investigated anti-cancer properties.
  • MicroRNAs play crucial roles in the development and progression of various cancers, including GI cancers.
  • Resveratrol's interaction with specific microRNAs may offer therapeutic benefits for GI neoplasms.

Conclusions:

  • Resveratrol demonstrates potential as a therapeutic agent for GI cancers through modulation of microRNA expression.
  • Understanding these molecular interactions is vital for developing novel, natural product-based treatments for GI cancers.
  • This review highlights the need for further investigation into resveratrol and microRNA pathways for effective GI cancer therapies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K